Articles: Academic/Research

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles
Browse

Articles

Displaying 1..10 of 13 - per page Next page
Order by

An Interview with Andrew Gay, Marketing Director of Huntingdon Life Sciences

Andrew Gay discusses some of the challenges faced at Huntingdon Life Sciences since the company was targeted by animal rights extremists. More

How To Prove When You Made Your Invention

A detailed account of all the actions required to prove when you made your invention More

BioIsrael Insight: Can-Fite Uses NIH-licensed Technology to Develop Anti-Tumor Drug

Can-Fite BioPharma, after quietly conducting several years of pre-clinical research, is about to begin Phase I trials for its new anti-tumor drug that could rival Amgen's $1 Billion blockbusterNeupogen, used as adjunctive treatment for chemotherapy More

Extended Incubation - Creation of New start-Ups

This article looks at how private business parks can support technology-led start-ups to increase survival rates. More

From Lay-Offs to Spin-Offs

Is the 'Silicon Valley effect' confined to buoyant regional economies with a strong research base? More

BioIsrael Insight: Accelerating Startups Through Local Clustering and International Networking

Eager BioGroup has developed a novel approach to accelerate the growth of early-stage biotech companies More

Hong Kong and Biotech, the Right Combination?

Over the past seven years, only about USD100 million has been invested in biotech-related projects by the Hong Kong government. However, this is not the only reason behind the lack of movement within the industry. More

Fifth framework programme - EU funding consortium agreements

he Fifth Framework Programme, covering research, technological development and demonstration activities, provides funding from the European Commission for certain thematic and horizontal programmes More

BioInsights -The CREATE Act: Protecting patentable inventions that arise from collaborative research

The Cooperative Research and Technology Enhancement ("CREATE") Act of 2004 was signed into law by President Bush on December 10, 2004. More

Innovation - an EU Update

A description of the broad policy lines for enhancing innovation in the European Union. More

Displaying 1..10 of 13 - per page Next page
Order by

Your selection

Industry sector: Academic/Research del

Browse By

Industry sector: Animal health; Biotech; Diagnostic; Drug delivery; Medical device; Pharmaceutical
Therapeutic target: Accident and Trauma; Allergy; Blood and forming organs; Cardiovascular; Central Nervous System; Dermatological; Endocrinology; Gastrointestinal; Genetic disorders; Genito-urinary; Hospital and Surgery; Immune related disorders; Infectious diseases; Metabolism; Musculoskeletal; Oncology; Oral Health; Other therapeutic; Respiratory; Sensory organ
Year: 2009; 2008; 2007; 2006; 2005; 2004; 2003; 2002; 2001; 2000; 1999

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us